Norman Swan
speaker
10,274 appearances
109 recordings
1 series
first heard Mar 2020
last heard 11 Aug
Norman Swan’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 2 in all, peaking in Aug 2026 with 1.
Appearances
So it's not that they're more worried about
about it, that they're putting a pause on it.
It's more that they want to make the right decision in terms of restriction and the b risk benefit analysis, 'cause remember, there's still covet around, plenty of it in the United States, and the risk of a you know of an uptick is significant.
Yes, and when you actually you know, people are free to go into this slide presentation that we'll put up on the Chronocast website and you'll see that when you actually see the results, it's much less scary.
You know, it just tells you what the story is and the pre existing conditions, for example.
So for example for example, nobody in these six women and they're all women, uh had a a blood clotting problem.
A pre existing blood clotting problem, thank you.
They all in this case had cerebralvenos venous sinus thrombosis, that's a cerebral vein thrombosis.
But some also and there was a publication in the New England Journal, which we'll also put on our website, um, of a woman who present a forty-eight-year-old woman who presented in Omaha, really very, very sick with the central vein throm thrombosis, clots in her animal.
abdomen as well and really quite ill, but again, just really being open about what is happening here.
You know, it's a very small number at this point and hard to generalise, but at least you get the story.
Yes.
And the only th they've got Astra, but the one that they've got on the shelf already it being produced, although there's been a bit of a lull because they had a problem with a manufacturing facility, is Johnson.
They've got Johnson in in millions of doses, and when they get their manufacturing organized properly um and safely, then they'll have a lot more and it's a potentially very valuable vaccine.
So they'll they'll put restrictions on it.
They're just wondering what the restrictions are going to be and they want time to actually think it out.
Yes.
I mean what what I'm hearing from sources is that yes, the numbers are being published, but they don't necessarily believe them.
There's still a strong view that we're holding back too many doses for second doses.
In other words, that there's twelve weeks between the first and second dose and some they're keeping back too much Astra vaccine when they could actually be releasing it to market.
Showing 661–680 of 10,274 · page 34 of 514
← Previous
Next →